Beijing Aosaikang Pharmaceutical (002755.SZ) released a profit forecast, with an estimated net profit of 150 million to 195 million yuan for the fiscal year 2024, turning losses into profits compared to the previous year.

Beijing Aosaikang Pharmaceutical (002755.SZ) released its 2024 performance forecast, expecting a net profit attributable to shareholders of the listed company of 150 million to 195 million yuan for the full year, turning losses into profits year-on-year. During the reporting period, the company's sales of anti-infection and chronic disease products grew rapidly, with its operating revenue increasing year-on-year and profitability further improving.